Barbara Ludwig

ORCID: 0000-0003-0771-5247
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Diabetes Management and Research
  • Xenotransplantation and immune response
  • Cannabis and Cannabinoid Research
  • Pluripotent Stem Cells Research
  • Hormonal Regulation and Hypertension
  • COVID-19 Clinical Research Studies
  • Genetic Associations and Epidemiology
  • Tissue Engineering and Regenerative Medicine
  • Pancreatitis Pathology and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Orthodontics and Dentofacial Orthopedics
  • Genetics and Neurodevelopmental Disorders
  • dental development and anomalies
  • 3D Printing in Biomedical Research
  • Virus-based gene therapy research
  • Metabolism, Diabetes, and Cancer
  • Immune Cell Function and Interaction
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Genetic and phenotypic traits in livestock
  • Diet, Metabolism, and Disease
  • Receptor Mechanisms and Signaling
  • Polyomavirus and related diseases
  • Craniofacial Disorders and Treatments

Paul Langerhans Institute Dresden
2015-2024

University Hospital Carl Gustav Carus
2015-2024

TU Dresden
2015-2024

Deutsches Diabetes-Zentrum e.V.
2014-2024

German Center for Diabetes Research
2013-2024

Heinrich Heine University Düsseldorf
2014-2024

Helmholtz Zentrum München
2015-2024

Center for Environmental Health
2023-2024

King Abdullah University of Science and Technology
2023

Center for Systems Biology Dresden
2023

Georg Ehret Patricia B. Munroe Kenneth Rice Murielle Bochud Andrew D. Johnson and 95 more Daniel I. Chasman Albert V. Smith Martin D. Tobin Germaine C. Verwoert Shih Jen Hwang Vasyl Pihur Péter Vollenweider Paul F. O’Reilly Najaf Amin Jennifer L. Bragg‐Gresham Alexander Teumer Nicole L. Glazer Lenore J. Launer Jing Zhao Yurii S. Aulchenko Simon Heath Siim Sõber Afshin Parsa Jian’an Luan Pankaj Arora Abbas Dehghan Feng Zhang Gavin Lucas Andrew A. Hicks Anne Jackson John F. Peden Toshiko Tanaka Philipp S. Wild Igor Rudan Wilmar Igl Yuri Milaneschi Alex Parker Cristiano Fava John C. Chambers Ervin R. Fox Meena Kumari Min Jin Go Pim van der Harst Wen Hong Linda Kao Marketa Sjögren D. G. Vinay M Alexander Yasuharu Tabara Sue Shaw‐Hawkins Peter H. Whincup YongMei Liu Gang Shi Johanna Kuusisto Bamidele O. Tayo Mark Seielstad Xueling Sim Khanh Dung Hoang Nguyen Terho Lehtimäki Giuseppe Matullo Ying Wu Tom R. Gaunt N. Charlotte Onland‐Moret Matthew N. Cooper Carl Platou Elin Org Rebecca Hardy Santosh Dahgam Jutta Palmen Véronique Vitart Peter S. Braund Tatiana Kuznetsova Cuno S.P.M. Uiterwaal Adebowale Adeyemo Walter Palmas Harry Campbell Barbara Ludwig Maciej Tomaszewski Ioanna Tzoulaki Colin N. A. Palmer Thor Aspelund Melissa N. Garcia Yen Pei C. Chang Jeffrey R. O’Connell Nanette Steinle Diederick E. Grobbee Dan E. Arking Sharon L.R. Kardia Alanna C. Morrison Dena Hernandez Samer S. Najjar Wendy L. McArdle David Hadley Morris J. Brown John Connell Aroon D. Hingorani Ian N.M. Day Debbie A. Lawlor John Beilby Robert Lawrence Robert Clarke

10.1038/nature10405 article EN Nature 2011-09-09

Significance Diabetes mellitus type 1 is an autoimmune disease that results in irreversible destruction of insulin-producing beta cells. Substantial advances have been made cell replacement therapies over the last decades. However, lack eligible donor organs and need for chronic immunosuppression to prevent rejection critically limit a widespread application these strategies. In this paper we present clinical success using bioartificial pancreas transplantation islets without affecting...

10.1073/pnas.1317561110 article EN Proceedings of the National Academy of Sciences 2013-10-28

Abstract Metabolic diseases are associated with an increased risk of severe COVID-19 and conversely, new-onset hyperglycemia complications preexisting diabetes have been observed in patients. Here, we performed a comprehensive analysis pancreatic autopsy tissue from patients using immunofluorescence, immunohistochemistry, RNA scope electron microscopy detected SARS-CoV-2 viral infiltration beta-cells all Using pseudoviruses, confirmed that isolated human islet cells permissive to infection....

10.1038/s41467-021-23886-3 article EN cc-by Nature Communications 2021-06-10

The current epidemic of diabetes with its overwhelming burden on our healthcare system requires better therapeutic strategies. Here we present a promising novel approach for curative strategy that may be accessible all insulin-dependent patients. We designed subcutaneous implantable bioartificial pancreas (BAP)-the "β-Air"-that is able to overcome critical challenges in clinical islet transplantation protocols: adequate oxygen supply the graft and protection donor islets against host immune...

10.3727/096368912x657341 article EN Cell Transplantation 2013-04-05

Islet transplantation is a feasible therapeutic alternative for metabolically labile patients with type 1 diabetes. The primary target stable glycemic control and prevention of complications associated diabetes by reconstitution endogenous insulin secretion. However, critical shortage donor organs, gradual loss in graft function over time, chronic need immunosuppression limit the indication islet to small group patients. Here we present promising approach address these limitations...

10.1073/pnas.1201868109 article EN Proceedings of the National Academy of Sciences 2012-03-05

Developing a device that protects xenogeneic islets to allow treatment and potentially cure of diabetes in large mammals has been major challenge the past decade. Using for transplantation is required light donor shortage number diabetic patients qualify islet transplantation. Until now, however, host immunoreactivity against graft drawback use porcine islets. Our study demonstrates applicability novel immunoprotective membrane allows successful xenotransplantation rat minipigs without...

10.1371/journal.pone.0070150 article EN cc-by PLoS ONE 2013-08-01

Transplantation of pancreatic islets is a promising strategy to alleviate the unstable blood-glucose control that some patients with diabetes type 1 exhibit and has seen many advances over years. Protection transplanted from immune system can be accomplished by encapsulation within hydrogel, most investigated which alginate. In this study, islet combined 3D extrusion bioprinting, an additive manufacturing method enables fabrication structures precise geometry produce macroporous hydrogel...

10.1002/adhm.201801631 article EN Advanced Healthcare Materials 2019-03-05

Significance Diabetes mellitus type 1 is an autoimmune disease that results in irreversible destruction of insulin-producing beta cells. Substantial advances have been made cell replacement therapies during the last decades. However, lack eligible donor organs and need for chronic immunosuppression to prevent rejection critically limit widespread application these strategies. In this manuscript, we present experimental study using a bioartificial pancreas device transplantation xenogeneic...

10.1073/pnas.1708420114 article EN Proceedings of the National Academy of Sciences 2017-10-16

Abstract Obese adipose tissue (AT) inflammation contributes critically to development of insulin resistance. The complement anaphylatoxin C5a receptor (C5aR) has been implicated in inflammatory processes and as regulator macrophage activation polarization. However, the role C5aR obesity AT not addressed. We engaged model diet-induced found that expression was significantly upregulated obese AT, compared with lean AT. In addition, present proximity macrophage-rich crownlike structures....

10.4049/jimmunol.1300038 article EN The Journal of Immunology 2013-09-17

Islet transplantation as a biological β-cell replacement therapy has emerged promising option for achieving restoration of metabolic control in type 1 diabetes patients. However, partial or complete loss islet graft function occurs relatively short time (months to few years) after implantation. The high rate early transplant dysfunction been attributed poorly viable and/or functional islets and is mediated by innate inflammatory response at the intravascular (hepatic) site critical lack...

10.1055/s-0030-1267916 article EN Hormone and Metabolic Research 2010-10-28

Islet-cell hormone release is modulated by signals from endothelial and endocrine cells within the islet. However, models of intraislet vascularization paracrine cell signaling are mostly based on rodent pancreas. We assessed architecture interaction vascular network in unperturbed human islets situ their potential to re-establish endogenous after transplantation vivo. prepared slices fresh pancreas tissue obtained nondiabetic patients undergoing partial pancreatectomy. In addition, we...

10.1210/en.2016-1184 article EN Endocrinology 2017-01-27

At the time first pancreas transplant was performed by Kelly and Lillehei in 1966, insulin therapy for diabetes generally available but administered a form that is known today as “conventional therapy.”1 In this era, many half of all juvenile onset diabetics did not reach age 55 years. Early mortality from accelerated cardiovascular disease, renal failure, hypoglycemia-related events were commonplace. The early low success rate transplantation comparison also suboptimal. As will be...

10.1097/tp.0000000000001055 article EN Transplantation 2016-02-01

Significance Adrenal insufficiency is a life-threatening disorder that requires complex and permanent hormone replacement strategy. All current schemes suffer from numerous problems, as they fail to restore circadian variations in secretion. Therefore, adrenal cell transplantation could be preferable therapeutic alternative for patients suffering primary dysfunction. This strategy critically limited, however, by the lack of suitable donors human organs requirement chronic immunosuppression....

10.1073/pnas.1500242112 article EN Proceedings of the National Academy of Sciences 2015-02-09

Transplantation of encapsulated islets can cure diabetes without immunosuppression, but oxygen supply limitations cause failure. We investigated a retrievable macroencapsulation device wherein are in planar alginate slab and supplied with exogenous from replenishable gas chamber. Translation to clinically-useful devices entails reduction size by increasing islet surface density, which requires increased chamber pO

10.1038/s41598-018-23862-w article EN cc-by Scientific Reports 2018-04-19

Pancreatic islets of Langerhans secrete hormones to regulate systemic glucose levels. Emerging evidence suggests that islet cells are functionally heterogeneous allow a fine-tuned and efficient endocrine response physiological changes. A precise description the molecular basis this heterogeneity, in particular linking animal models human islets, is an important step towards identifying factors critical for cell function pathophysiological conditions. In study, we used single-cell RNA...

10.1016/j.molmet.2022.101595 article EN cc-by Molecular Metabolism 2022-09-13
Coming Soon ...